PRICE T ROWE ASSOCIATES INC /MD/
Position in AGIO — Agios Pharmaceuticals, Inc.
CIK 80255
BALTIMORE, MD
Position in AGIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,125,828
-$1,982,000 QoQ
Shares Held
218,966
-26.7% QoQ
Ownership
0.367%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. AGIO ranks #126 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in AGIO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,125,828 | 218,966 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,107,828 | 298,783 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,363,256 | 637,886 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $66,509,491 | 1,656,938 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $75,641,520 | 2,274,249 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $67,429,642 | 2,301,353 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $79,637,425 | 2,423,537 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $125,848,507 | 2,832,512 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $119,755,407 | 2,777,259 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $58,859,914 | 2,012,993 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $36,180,108 | 1,624,612 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $40,246,221 | 1,626,110 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $36,628,860 | 1,293,392 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $29,027,119 | 1,263,697 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $41,563,846 | 1,480,194 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $41,754,655 | 1,476,473 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $56,466,679 | 2,546,986 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $78,644,303 | 2,701,625 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $94,623,329 | 2,878,714 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $139,868,697 | 3,030,741 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $164,405,419 | 2,983,223 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $152,875,675 | 2,960,412 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $128,790,712 | 2,972,322 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $108,836,315 | 3,109,609 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $175,270,699 | 3,277,313 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $95,644,500 | 2,695,730 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||